These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7025589)

  • 1. [Peripheral dopaminergic receptors].
    Bogaert M; Buylaert W; Lefebvre R; Willems J
    Actual Pharmacol (Paris); 1981; 33():57-75. PubMed ID: 7025589
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peripheral dopamine DA1-type receptors: their localization, functional role and possible clinical implications].
    Mannelli M; Pupilli C; Baldi E; DeFeo ML
    Cardiologia; 1987 Dec; 32(12):1617-21. PubMed ID: 2965980
    [No Abstract]   [Full Text] [Related]  

  • 3. The peripheral dopaminergic system. Basic and clinical advances.
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):1S-2S. PubMed ID: 1974437
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopaminergic receptors: a new antihypertensive mechanism.
    Velasco M; Contreras F; Cabezas GA; Bolívar A; Fouillioux C; Hernández R
    J Hypertens Suppl; 2002 Jun; 20(3):S55-8. PubMed ID: 12184056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dopaminergic stimulation in cardiology: its current status and future strategies].
    Cherchi A; Mercuro G
    Cardiologia; 1987 Dec; 32(12):1631-9. PubMed ID: 3329022
    [No Abstract]   [Full Text] [Related]  

  • 6. The peripheral dopaminergic system: morphological analysis, functional and clinical applications.
    Amenta F; Ricci A; Tayebati SK; Zaccheo D
    Ital J Anat Embryol; 2002; 107(3):145-67. PubMed ID: 12437142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dopamine in the pathogenesis of hypertension.
    Jose PA; Eisner GM; Felder RA
    Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S10-3. PubMed ID: 10386248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral dopaminergic receptors. Physiological and pharmaceutical aspects of therapeutic importance.
    van Rooyen JM; Offermeier J
    S Afr Med J; 1981 Mar; 59(10):329-32. PubMed ID: 7008209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dopaminergic systems and their targets].
    Tassin JP
    Encephale; 1989; 15 Spec No():63-72. PubMed ID: 2663448
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent aspect of the role of peripheral dopamine and its receptors in the pathogenesis of hypertension.
    Shigetomi S; Fukuchi S
    Fukushima J Med Sci; 1994 Dec; 40(2):69-83. PubMed ID: 7642168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptors in hypertension.
    Bek MJ; Eisner GM; Felder RA; Jose PA
    Mt Sinai J Med; 2001 Nov; 68(6):362-9. PubMed ID: 11687863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The renal dopaminergic system and arterial hypertension].
    Pestana M; Guerra L
    Rev Port Cardiol; 1996 Dec; 15(12):893-902. PubMed ID: 9052965
    [No Abstract]   [Full Text] [Related]  

  • 13. Conditioned dopaminergic activity.
    Schiff SR
    Biol Psychiatry; 1982 Feb; 17(2):135-54. PubMed ID: 7200377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The renal dopaminergic system in chronic diseases of the renal parenchyma].
    Pestana M
    Rev Port Cardiol; 1998; 17(7-8):635-43. PubMed ID: 9741219
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications.
    Lokhandwala MF; Barrett RJ
    J Auton Pharmacol; 1982 Sep; 2(3):189-215. PubMed ID: 6754737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptors in C. elegans.
    Suo S; Ishiura S; Van Tol HH
    Eur J Pharmacol; 2004 Oct; 500(1-3):159-66. PubMed ID: 15464029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endogenous dopaminergic regulation of aldosterone secretion. Studies of pathophysiologic value].
    Jungmann E
    Fortschr Med; 1987 Jun; 105(17):337-9. PubMed ID: 3609999
    [No Abstract]   [Full Text] [Related]  

  • 18. Intestinal pharmacomanometry and glucose tolerance: evidence for two antagonistic dopaminergic mechanisms in the human.
    Lechin F; van der Dijs B
    Biol Psychiatry; 1981 Oct; 16(10):969-86. PubMed ID: 7306619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dopamine receptor subtypes].
    Janković SM; Milovanović D; Mitrović M; Dukić-Dejanović S
    Med Pregl; 1996; 49(7-8):281-5. PubMed ID: 8926944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The dopaminergic system and addictions].
    Corominas-Roso M; Roncero C; Bruguera E; Casas M
    Rev Neurol; 2007 Jan 1-15; 44(1):23-31. PubMed ID: 17199226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.